Pulmonary manifestations of HIV infection in the era of highly active antiretroviral therapy.
about
HIV-associated lung infections and complications in the era of combination antiretroviral therapy.Risk of pneumocystosis after early discontinuation of prophylaxis among HIV-infected patients receiving highly active antiretroviral therapy.Measurement of antiretroviral drugs in the lungs of HIV-infected patients.Update on opportunistic infections in the era of effective antiretroviral therapyImaging lung manifestations of HIV/AIDS.Pneumonia and influenza hospitalization in HIV-positive seniorsPneumonia due to antibiotic resistant Streptococcus pneumoniae and Pseudomonas aeruginosa in the HAART eraUse of Oropharyngeal Washes to Diagnose and Genotype Pneumocystis jirovecii.Impact of highly active antiretroviral therapy on organ-specific manifestations of HIV-1 infection.Bacterial infections in adult HIV-infected patients.Outcome of critically ill human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.Trends of mortality and cause of death among HIV-infected patients in Korea, 1990-2011Th17 cells and mucosal host defense.Pulmonary toxoplasmosis in human immunodeficiency virus-infected patients in the era of antiretroviral therapy.Life-threatening complications of HIV infection.Clinical review: Respiratory failure in HIV-infected patients--a changing picture.Interleukin-17 in pulmonary host defense.Changes in the socio-demographics, risk behaviors, clinical and immunological profile of a cohort of the Puerto Rican population living with HIV: an update of the Retrovirus Research Center (1992-2008)Association of bronchoalveolar lavage yield with chest computed tomography findings and symptoms in immunocompromised patients.Comparing clinical outcomes in HIV-infected and uninfected older men hospitalized with community-acquired pneumoniaMultilocus microsatellite genotyping array for investigation of genetic epidemiology of Pneumocystis jirovecii.HIV-related pneumococcal disease prevention in adults.Prescription of Pneumocystis Jiroveci Pneumonia Prophylaxis in HIV-Infected Patients.Refractory acute respiratory failure due to Pneumocystis jiroveci (PCP) and Cytomegalovirus (CMV) pneumonitis: A case report and review of literature.Effectiveness of polysaccharide pneumococcal vaccine in HIV-infected patients: a case-control study.Prevalence of and factors related to tuberculosis in seropositive human immunodeficiency virus patients at a reference center for treatment of human immunodeficiency virus in the southern region of the state of Rio Grande do Sul, Brazil.Cellular immune response to pulmonary infections in HIV-infected individuals hospitalized with diverse grades of immunosuppression.Human immunodeficiency virus associated pulmonary conditions leading to hospital admission and the pulmonary rehabilitation services received by patients at two central hospitals in Harare.
P2860
Q27693307-0C1B2494-7DC5-4CE7-B7C5-BF9E91321C87Q33584240-3062371F-8B27-4C7E-A94B-0283DB4022F9Q33818018-D39E1F8D-C7D0-4E99-A778-06322739F638Q34085853-FFE26F6F-B370-4B1C-B7D1-090C87FD5468Q34195916-4EE50A34-6636-4CCF-8724-7FAEE764A159Q35383359-FE8B4915-72CB-4A09-A717-6AA708E7986BQ35518390-10E84F70-F6D8-40AC-ABA4-7B2DEDDD624DQ35837803-DE82CB91-3087-4A39-89F8-C1D7600C0D61Q36088274-61C480AF-ED00-439A-916C-05EE2F7C3A89Q36281588-D06FFA13-8B65-4878-83BD-2DCAF3F5B1AAQ36310358-DEFE95BE-BC72-4384-B8D7-37F1488B38B8Q36536356-D519CC41-BF2D-4D35-90D6-0388DE8AD440Q36540657-AD3EB771-2E44-420C-B778-F93DAE3C6F8EQ36566224-717BF647-AA6A-4BDE-9471-884B55D8E6DBQ36800706-A46D79AB-38D0-4099-BFBE-F74FD3ED802DQ36998358-31BF3D7D-D6F2-43B6-8B6C-36FEA1B18DD9Q37030659-506661CB-6B39-4CE4-90E8-0BE3BEBEB0B0Q37051379-EFB00568-733C-4F8A-95EF-8D18C67090BAQ37065497-024D0D89-1EAF-48D9-87E1-1C8076E5922AQ37240889-D1168362-6375-4C68-B9AD-933A57D5FD68Q37713756-2B4B1D9F-E0C2-4A1F-87FC-76AD4C796061Q38947827-3A42AB35-A6D3-4B09-82A1-055EC5BBDB06Q39388847-F20717AC-18C9-4437-A69E-55BD59E9562EQ40054529-E8C25A6E-9F9F-4E65-938D-AC573F39D4DDQ43926822-4D3380C8-4496-4D30-A559-FE07A2A630E2Q45407626-2A23FC0C-81C4-4EED-ACC0-BD3585DEF8D8Q53635763-FA4FA119-02D3-4263-9CEB-CE7D75D7D0B2Q55434353-FC445583-3164-41D4-A706-A3EA95A99C71
P2860
Pulmonary manifestations of HIV infection in the era of highly active antiretroviral therapy.
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Pulmonary manifestations of HI ...... active antiretroviral therapy.
@ast
Pulmonary manifestations of HI ...... active antiretroviral therapy.
@en
Pulmonary manifestations of HI ...... active antiretroviral therapy.
@nl
type
label
Pulmonary manifestations of HI ...... active antiretroviral therapy.
@ast
Pulmonary manifestations of HI ...... active antiretroviral therapy.
@en
Pulmonary manifestations of HI ...... active antiretroviral therapy.
@nl
prefLabel
Pulmonary manifestations of HI ...... active antiretroviral therapy.
@ast
Pulmonary manifestations of HI ...... active antiretroviral therapy.
@en
Pulmonary manifestations of HI ...... active antiretroviral therapy.
@nl
P356
P1433
P1476
Pulmonary manifestations of HI ...... active antiretroviral therapy.
@en
P2093
O'Donnell AE
P304
P356
10.1378/CHEST.120.6.1888
P407
P577
2001-12-01T00:00:00Z